The work Mikhail Blagosklonny has done regarding target cancer therapies has allowed people to go into environments and situations where cancer patients did not feel like they could go in the past.
Mikhail Blagosklonny has helped people learn about different aspects of cancer and how it advances with age. Why do cells die and how do you differentiate between good cells and bad cells? These are the crucial matters that Mikhail Blagosklonny learned about at the University of Saint Petersburg. He is part of the editorial board for Cell Death and Differentiation.
Follow Mikhail on Google Scholar
Through his scientific research, Mikhail Blagosklonny believed that aging and cancer resulted from TOR signaling, which in the cell metabolism is a central regulator. Drugs such as rapamycin could treat aging and help a person live a longer life in the future. During treatments that are diagnosed, healthy cells would not be damaged but cancer cells would be. This method was tested in animal lab reports.
How can cells be shaped in a proper direction to make sure patients are happy and healthy? How can cells able to handle different long term treatment? Cell Cycle is a peer reviewed journal that people can gain a wide variety of crucial information. A quality publisher like this benefits from the work of Mikhail Blagosklonny, as we try to see where the future of treatments is headed.
Scholars all over the world would benefit from this research as they learn about how diet can have an impact on cell formation and potential duplication.
Check Mikhail’s profile in LinkedIn